New AAV Vector Suspension platform complements integrated capabilities - enabling cell and gene therapies to be developed, manufactured, and released faster and with greater predictability globally.
PR Newswire
PHILADELPHIA, Jan. 13, 2020
PR Newswire
PHILADELPHIA, Jan. 13, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey